Location History:
- Madrid, ES (2007 - 2009)
- Madrdid, ES (2009)
Company Filing History:
3 out of 81 
2 out of 8 
1 out of 1 Years Active: 2007-2009
Title: **Andrés Francesch: Pioneering Antitumoral Innovations in Madrid**
Introduction
Andrés Francesch is an esteemed inventor based in Madrid, Spain, recognized for his remarkable contributions to the field of medicinal chemistry. With three patents to his name, he has significantly advanced the development of compounds that play a crucial role in antitumoral therapy.
Latest Patents
Francesch's latest patents showcase his innovative approaches in synthesizing complex chemical structures. One notable patent involves a synthetic process for the manufacture of an ecteinascidin compound. This process revolves around creating compounds with a fused ring structure, characterized by a spiroamine-1,4-bridge. He details the method of forming a 1,4 bridge using a 1-labile, 10-hydroxy, 18-protected hydroxyl, di-6,8-en-5-one fused ring compound. Following the formation of the 1,4 bridge, the C-18 protection is removed prior to the introduction of the spiroamine. Another significant patent developed by Francesch is focused on antitumoral analogs of lamellarins, where he presents new lamellarins of a general formula alongside pharmaceutically acceptable salts, derivatives, prodrugs, or stereoisomers.
Career Highlights
Throughout his career, Francesch has been affiliated with notable companies in the pharmaceutical sector, including Pharma Mar, S.A. and Pharmamar. His work at these organizations has facilitated the translation of scientific research into impactful therapeutic solutions for patients suffering from various malignancies.
Collaborations
Francesch's journey is marked by collaborations with esteemed colleagues such as Carolina Fernández and José Luis Chicharro. These professional relationships highlight his commitment to teamwork and innovation in the pharmaceutical research community.
Conclusion
Andrés Francesch continues to make strides in the field of medicinal chemistry through his inventive processes and collaborations. His dedication to developing novel compounds that target cancer illustrates the vital role of inventors in advancing medical science and improving patient outcomes.